Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US Supply Of OTC COVID-19 Tests Gets Boost Through $231.8M Contract For Australian Firm

02 Feb 2021

The Biden administration has given Ellume $213.8M to build a factory in the US to produce their at-home OTC COVID-19 test. — The Biden administration awards contract for supply of Ellmune's COVID-19 Home Test. • Source: Source: Shutterstock / Ellume Health (Shutterstock)

Related Content

First COVID-19 At-Home Test That Doesn’t Require A Prescription Authorized By The FDA

15 Dec 2020

Senate Passes Fourth COVID-19 Spending Package, Includes $25Bn For Additional Testing, Contact Tracing

22 Apr 2020

OTC Diagnostics Forecast: Growing With Pandemic But High Bar For Approval Could Slow Spread

13 Dec 2020

Abbott Mass Distributes Rapid COVID-19 Tests, Offers App So Consumers Can Display Test Results

13 Jan 2021

Additional Topics

Australia Asia Pacific International United States OTC Devices Coronavirus COVID-19 Manufacturing Commercial Companies FDA Policy Politics Regulation Consumer

More from Asia

More from Geography

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.